Risk of Hematologic Malignancies in Patients with Inflammatory Bowel Disease: A Meta-Analysis of Cohort Studies

키워드

참고문헌 (52)

1. Ananthakrishnan AN, "Changing global epidemiology of inflammatory bowel diseases : sustaining health care delivery into the 21st century", Clin Gastroenterol Hepatol, 18, pp.1252~1260 (2020)
2. Chen X, "Evolving trends and burden of inflammatory bowel disease in Asia, 1990-2019 : a comprehensive analysis based on the global burden of disease study", J Epidemiol Glob Health, 13, pp.725~739 (2023)
3. Park KT, "The cost of inflammatory bowel disease : an initiative from the Crohn's & Colitis Foundation", Inflamm Bowel Dis, 26, pp.1~10 (2020)
4. Komaki Y, "Risk of cancers in patients with pediatric inflammatory bowel diseases : a systematic review and meta-analysis", J Pediatr, 229, pp.102~117 (2021)
5. Wheat CL, "Worldwide incidence of colorectal cancer, leukemia, and lymphoma in inflammatory bowel disease : an updated systematic review and meta-analysis", Gastroenterol Res Pract, 2016, pp.1632439~ (2016)
6. Lopez A, "Thiopurines and myeloid disorders : is more caution needed when treating inflammatory bowel disease patients?", Expert Rev Clin Immunol, 10, pp.1563~1565 (2014)
7. Lo B, "The risk of extraintestinal cancer in inflammatory bowel disease : a systematic review and meta-analysis of population-based cohort studies", Clin Gastroenterol Hepatol, 19, pp.1117~1138 (2021)
8. Taborelli M, "Risk of intestinal and extra-intestinal cancers in patients with inflammatory bowel diseases : a population-based cohort study in northeastern Italy", PLoS One, 15, pp.e0235142~ (2020)
9. Stang A, "Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses", Eur J Epidemiol, 25, pp.603~605 (2010)
10. Pandis N, "The chi-square test", Am J Orthod Dentofacial Orthop, 150, pp.898~899 (2016)
11. Kanters S, "Fixed-and random-effects models", Methods Mol Biol, 2345, pp.41~65 (2022)
12. Lin L, "Quantifying publication bias in meta-analysis", Biometrics, 74, pp.785~794 (2018)
13. Ashworth LA, "Lymphoma risk in children and young adults with inflammatory bowel disease : analysis of a large single-center cohort", Inflamm Bowel Dis, 18, pp.838~843 (2012)
14. Lakatos PL, "The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases : results from a population-based cohort in Eastern Europe", J Crohns Colitis, 7, pp.385~391 (2013)
15. Yano Y, "Cancer risk in Japanese Crohn's disease patients : investigation of the standardized incidence ratio", J Gastroenterol Hepatol, 28, pp.1300~1305 (2013)
16. Yadav S, "Effect of medications on risk of cancer in patients with inflammatory bowel diseases : a population-based cohort study from Olmsted County, Minnesota", Mayo Clin Proc, 90, pp.738~746 (2015)
17. van den Heuvel TR, "Inflammatory bowel disease, cancer and medication : cancer risk in the Dutch population-based IBDSL cohort", Int J Cancer, 139, pp.1270~1280 (2016)
18. Wang LH, "Higher risk for hematological malignancies in inflammatory bowel disease : a nationwide population-based study in Taiwan", Am J Gastroenterol, 111, pp.1313~1319 (2016)
19. So J, "Cancer risk in 2621 Chinese patients with inflammatory bowel disease : a populationbased cohort study", Inflamm Bowel Dis, 23, pp.2061~2068 (2017)
20. Malham M, "The incidence of cancer and mortality in paediatric onset inflammatory bowel disease in Denmark and Finland during a 23-year period : a population-based study", Aliment Pharmacol Ther, 50, pp.33~39 (2019)
21. Scharl S, "Malignancies in inflammatory bowel disease : frequency, incidence and risk factorsresults from the Swiss IBD Cohort Study", Am J Gastroenterol, 114, pp.116~126 (2019)
22. Zhang H, "Risk of malignancy in patients with inflammatory bowel disease : a population-based cohort study from China", Int J Cancer, 150, pp.1770~1778 (2022)
23. Olén O, "Increasing risk of lymphoma over time in Crohn’s disease but not in ulcerative colitis : a Scandinavian cohort study", Clin Gastroenterol Hepatol, 21, pp.3132~3142 (2023)
24. Yu J, "Risk of malignant lymphomas in patients with inflammatory bowel disease : a population-based cohort study", BMJ Open Gastroenterol, 10, pp.e001037~ (2023)
25. Lopez A, "Increased risk of acute myeloid leukemias and myelodysplastic syndromes in patients who received thiopurine treatment for inflammatory bowel disease", Clin Gastroenterol Hepatol, 12, pp.1324~1329 (2014)
26. Chiorean MV, "Incidence and risk factors for lymphoma in a singlecenter inflammatory bowel disease population", Dig Dis Sci, 56, pp.1489~1495 (2011)
27. Beaugerie L, "Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease : a prospective observational cohort study", Lancet, 374, pp.1617~1625 (2009)
28. Palli D, "Hodgkin's disease risk is increased in patients with ulcerative colitis", Gastroenterology, 119, pp.647~653 (2000)
29. Lewis JD, "Inflammatory bowel disease is not associated with an increased risk of lymphoma", Gastroenterology, 121, pp.1080~1087 (2001)
30. Jung JM, "The risk of lymphoproliferative disorders and skin cancers in patients with psoriasis and inflammatory bowel disease administered biologics", Dermatol Ther, 2023, pp.9224241~ (2023)
31. Farrell RJ, "Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low", Gut, 47, pp.514~519 (2000)
32. Yan WH, "HLA-G expression in hematologic malignancies", Expert Rev Hematol, 3, pp.67~80 (2010)
33. Martín-Lorenzo A, "Infection exposure is a causal factor in B-cell precursor acute lymphoblastic leukemia as a result of Pax5-inherited susceptibility", Cancer Discov, 5, pp.1328~1343 (2015)
34. Ye B, "Early detection and intervention of clonal hematopoiesis for preventing hematological malignancies", Cancer Lett, 538, pp.215691~ (2022)
35. Cumbo C, "Clonal hematopoiesis at the crossroads of inflammatory bowel diseases and hematological malignancies : a biological link?", Front Oncol, 12, pp.873896~ (2022)
36. Kaner J, "Clonal hematopoiesis and premalignant diseases", Cold Spring Harb Perspect Med, 10, pp.a035675~ (2020)
37. Qiu P, "The gut microbiota in inflammatory bowel disease", Front Cell Infect Microbiol, 12, pp.733992~ (2022)
38. Reddy BS, "Effect of high-risk diets for colon carcinogenesis on intestinal mucosal and bacterial beta-glucuronidase activity in F344 rats", Cancer Res, 37, pp.3533~3536 (1977)
39. Knasmüller S, "Impact of bacteria in dairy products and of the intestinal microflora on the genotoxic and carcinogenic effects of heterocyclic aromatic amines", Mutat Res, 480-481, pp.129~138 (2001)
40. Shi Z, "Emerging roles for the gut microbiome in lymphoid neoplasms", Clin Med Insights Oncol, 15, pp.11795549211024197~ (2021)
41. Wotherspoon AC, "Helicobacter pylori-associated gastritis and primary Bcell gastric lymphoma", Lancet, 338, pp.1175~1176 (1991)
42. Ferrero RL, "Outbred mice with long-term Helicobacter felis infection develop both gastric lymphoid tissue and glandular hyperplastic lesions", J Pathol, 191, pp.333~340 (2000)
43. Enno A, "MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis : a mouse model of Helicobacter pylori-induced gastric lymphoma", Am J Pathol, 147, pp.217~222 (1995)
44. Dai C, "Nonclostridium difficile enteric infection and the risk of developing inflammatory bowel disease : a systematic review and meta-analysis", Saudi J Gastroenterol, 26, pp.299~305 (2020)
45. Michaux M, "Spatial cluster mapping and environmental modeling in pediatric inflammatory bowel disease", World J Gastroenterol, 29, pp.3688~3702 (2023)
46. Aggarwal BB, "Historical perspectives on tumor necrosis factor and its superfamily : 25 years later, a golden journey", Blood, 119, pp.651~665 (2012)
47. Nocturne G, "Impact of anti-TNF therapy on NK cells function and on immunosurveillance against B-cell lymphomas", J Autoimmun, 80, pp.56~64 (2017)
48. Levhar N, "Propagation of EBVdriven lymphomatous transformation of peripheral blood B cells by immunomodulators and biologics used in the treatment of inflammatory bowel disease", Inflamm Bowel Dis, 26, pp.1330~1339 (2020)
49. Brenner DJ, "Computed tomography : an increasing source of radiation exposure", N Engl J Med, 357, pp.2277~2284 (2007)
50. Roingeard C, "Passive environmental residential exposure to agricultural pesticides and hematological malignancies in the general population : a systematic review", Environ Sci Pollut Res Int, 28, pp.43190~43216 (2021)
51. Coste A, "Residential exposure to solar ultraviolet radiation and incidence of childhood hematological malignancies in France", Cancer Causes Control, 26, pp.1339~1349 (2015)
52. Tian Z, "Index-based dietary patterns and inflammatory bowel disease : a systematic review of observational studies", Adv Nutr, 12, pp.2288~2300 (2021)

관련 논문AI추천